Select a Region

North America

Newscenter

Browsing Archive: BlogBlog | EVERSANA - Part 5

Posted on 1月 22, 20241/22/24

EVERSANA’s High-Quality HEOR Methods Recognized in Published Independent Review

Posted on 1月 15, 20241/15/24

HemGenix Shines in Collaborative ITC Analysis: EVERSANA and CSL Behring Propel Gene Therapy to the Forefront in Hemophilia B Treatment

Posted on 1月 9, 20241/9/24

Impact of the European Union Medical Device Regulation Extension on Legacy Devices

Posted on 1月 9, 20241/9/24

An Impactful Year for Global Regulation of Digital Health

Posted on 12月 14, 202312/14/23

Embracing the Future: A 2024 Outlook on Healthcare and Technology Trends

Posted on 12月 8, 202312/8/23

Seven Key Takeaways From a Week at AWS re:Invent 2023

Posted on 11月 7, 202311/7/23

The Data-Driven Revolution: AI’s Impact on Pharmaceutical Quality in Digital Therapy

Posted on 11月 6, 202311/6/23

VOICE OF THE CUSTOMER: Payer Pharmacy Directors Report ‘Back-to-Basics’ Contracting, Product Updates, and Pipeline Forecasts Drive Pharma Company Perceptions

Posted on 10月 31, 202310/31/23

Unveiling the Future: AI Opportunities in FDA Compliance, Insights from the OPQ Symposium

Posted on 10月 23, 202310/23/23

Adapting to Change: Examining the Implications of New EU Regulations on Commercialisation from the Perspectives of Patients, Providers, and Pharma Companies

Blog